Zdrowie i gospodarka · 17/12/2021
FDA Announces Draft Guidance for Industry on Inspection of Injectable Products for Visible Particulates
The FDA is releasing a draft guidance to help industry develop and implement a holistic approach to controlling visible particulates in injectable products, which can pose patient safety risks.